A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies
2006

Novel Methylation Markers in Cancer

Sample size: 20 publication 10 minutes Evidence: high

Author Information

Author(s): David S. Shames, Luc Girard, Boning Gao, Mitsuo Sato, Cheryl M. Lewis, Narayan Shivapurkar, Aixiang Jiang, Charles M. Perou, Young H. Kim, Jonathan R. Pollack, Kwun M. Fong, Chi-Leung Lam, Maria Wong, Yu Shyr, Rita Nanda, Olufunmilayo I. Olopade, William Gerald, David M. Euhus, Jerry W. Shay, A. F. Gazdar, John D. Minna

Primary Institution: The University of Texas Southwestern Medical Center at Dallas

Hypothesis

The study aims to identify new cancer-specific methylation markers that could be useful for early cancer detection.

Conclusion

The study identified multiple genes that are frequently methylated in primary lung, breast, colon, and prostate cancers, suggesting common methylation patterns across these malignancies.

Supporting Evidence

  • 132 genes with 5' CpG islands were identified as candidates for methylation analysis.
  • 31 genes showed acquired methylation in tumors but not in normal tissues.
  • Seven loci were frequently methylated in both breast and lung cancers.
  • Four genes showed extensive methylation across all four epithelial tumors studied.
  • The study suggests commonalities in promoter methylation profiles across different cancer types.

Takeaway

Researchers found that certain genes are turned off in cancer cells because they are covered in a chemical called methylation, which can help doctors find cancer earlier.

Methodology

The study used high-throughput global expression profiling and methylation-specific PCR to analyze gene expression and methylation patterns in lung cancer and adjacent normal tissues.

Potential Biases

Potential bias in sample selection and the influence of tumor microenvironment on methylation patterns.

Limitations

The study may have missed some methylation markers due to the limitations of microarray technology.

Participant Demographics

The study included 20 primary lung cancer patients, with a mean age of 61 years, comprising 76 males and 31 females.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030486

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication